Study Evaluating Bifeprunox in Bipolar Depression

Completed · Phase 3 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.

Key facts

Study ID
NCT00134459
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
434
Starts
2005-06-01
Expected to finish
2006-05-01
Last updated by the study team
2013-02-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.